Hendrik Wolf

1.1k citations

30 papers · 744 indexed · h-index 14

Impact in

Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Dermatology top 1%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies

Papers in ⓘ

Immunology and Allergy 25
- Allergic Rhinitis and Sensitization 25
- Food Allergy and Anaphylaxis Research 7
Physiology 16
- Asthma and respiratory diseases 15

Co-authors: J Schnitker (6 shared papers)Jörg Schnitker (11 shared papers)Randolf Brehler (4 shared papers)Bernhard Przybilla (3 shared papers)Franziska Ruëff (2 shared papers)Thomas Werfel (1 shared paper)Margitta Worm (1 shared paper)T. Ruzicka (1 shared paper)
Journals: Allergy (6 papers)Journal of Allergy and Clinical Immunology (4 papers)Clinical and Translational Allergy (2 papers)World Allergy Organization Journal (1 paper)Annals of the Rheumatic Diseases (1 paper)
Partner nations: Germany Denmark Belgium

In The Last Decade

Hendrik Wolf

26 papers receiving 680 citations

Peers

Countries citing papers authored by Hendrik Wolf

Since Specialization

Citations

This map shows the geographic impact of Hendrik Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hendrik Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hendrik Wolf more than expected).

Fields of papers citing papers by Hendrik Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hendrik Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hendrik Wolf. The network helps show where Hendrik Wolf may publish in the future.

Co-authors

The 25 scholars most cited alongside Hendrik Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hendrik Wolf Line = papers co-authored together Hendrik Wolf links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi‐centre, randomized, dose–response study Allergy ·Thomas Werfel, Kristine Breuer, Franziska Ruëff, Bernhard Przybilla, Margitta Worm, M. Grewe, T. Ruzicka, Randolf Brehler, Hendrik Wolf, J Schnitker, Alexander Kapp	2006	176
2	A prospective, randomized, double‐blind, placebo‐controlled multi‐centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen Allergy ·Claudia Rolinck‐Werninghaus, Hendrik Wolf, C. Liebke, J. C. Baars, Joep M. A. Lange, Matthias Kopp, J. Hammermann, W Leupold, Peter H. Bartels, Armin Gruebl, C.-P. Bauer, J Schnitker, Ulrich Wahn, B. Niggemann	2004	94
3	Expandable tubular stents for treatment of arterial occlusive diseases: experimental and clinical results. Work in progress. Radiology ·E. P. Strecker, Dieter Liermann, Klemens H. Barth, Hendrik Wolf, N. Freudenberg, Geoffrey Berg, Manfred Westphal, P. Tsikuras, Michael A. Savin, Bernhard Schneider	1990	82
4	Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections Journal of Allergy and Clinical Immunology ·Randolf Brehler, Hendrik Wolf, Birgitta Kütting, Jörg Schnitker, Thomas J. Luger	2000	74
5	Bromocriptine lessens the incidence of mortality in L-Dopa-treated parkinsonian patients: Prado-study discontinued European Journal of Clinical Pharmacology ·H. Przuntek, D. Welzel, E. Blümner, W Danielczyk, H. Letzel, H. Kaiser, P. H. Kraus, Peter Riederer, D. Schwarzmann, Hendrik Wolf, K. Überla	1992	49
6	Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations Allergy ·Franziska Ruëff, Hendrik Wolf, J Schnitker, Johannes Ring, Bernhard Przybilla	2004	46
7	The effect of short-term immunotherapy with molecular standardized grass and rye allergens on eosinophil cationic protein and tryptase in nasal secretions Journal of Allergy and Clinical Immunology ·Ludger Klimek, Hendrik Wolf, Torsten Mewes, Dirk Dormann, Angelika B. Reske‐Kunz, Jörg Schnitker, Wolf J. Mann	1999	40
8	Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens Allergy ·B.-R. Balda, Hendrik Wolf, C. Baumgarten, Ludger Klimek, Gerd Rasp, G. Kunkel, Sebastian Müller, Wolf J. Mann, B. Hauswald, Werner J. Heppt, Bernhard Przybilla, Ulrich Amon, Ralf Bischoff, G Becher, Scott L. Hummel, Peter J. Frosch, Thomas Rustemeyer, Lothar Jäger, Randolf Brehler, J Schnitker	1998	36
9	The Effects of Short‐Term Immunotherapy Using Molecular Standardized Grass and Rye Allergens Compared with Symptomatic Drug Treatment on Rhinoconjunctivitis Symptoms, Skin Sensitivity, and Specific Nasal Reactivity Otolaryngology ·Ludger Klimek, T. Mewes, Hendrik Wolf, Inga Hansen, J Schnitker, Wolf J. Mann	2005	20
10	Effect of Pollen-Specific Sublingual Immunotherapy on Oral Allergy Syndrome World Allergy Organization Journal ·Karl‐Christian Bergmann, Hendrik Wolf, Jörg Schnitker	2008	16
11	Health-Related Quality of Life During Routine Treatment with the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-Interventional Observational Study Clinical Drug Investigation ·(unknown), Andreas Horn, Herbert Zeuner, Hendrik Wolf, Jörg Schnitker, Eike Wüstenberg	2016	16
12	Immunologic Effect and Tolerability of Intra-Seasonal Subcutaneous Immunotherapy With an 8-Day Up-Dosing Schedule to 10,000 Standardized Quality-Units: A Double-Blind, Randomized, Placebo-Controlled Trial Clinical Therapeutics ·Oliver Pfaar, Hendrik Wolf, Ludger Klimek, Jörg Schnitker, Eike Wüstenberg	2012	16
13	Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio Allergy ·Oliver Pfaar, Kirsten Jung, Hendrik Wolf, Elke Decot, Jörg Kleine‐Tebbe, Ludger Klimek, E. G. Wüstenberg	2012	16
14	Is allergy immunotherapy with birch sufficient to treat patients allergic to pollen of tree species of the birch homologous group? Allergy ·Jörg Kleine‐Tebbe, Torsten Zuberbier, Thomas Werfel, Matthias Krüll, Martin Wagenmann, Niels Johansen, Peter Adler Würtzen, Hendrik Wolf, Victoria Mücke, Eike Wüstenberg, Tilo Biedermann	2019	15
15	Safety and Tolerability of an Intra-seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet: A Non-interventional Observational Study Investigating the Feasibility During Routine Administration Clinical Drug Investigation ·Jan-Alexander Schwab, Hendrik Wolf, Jörg Schnitker, Eike Wüstenberg	2013	11
16	[Gabexate mesilate in the therapy of acute pancreatitis. Multicenter study of tolerance of a high intravenous dose (4 g/day)]. PubMed ·Markus Büchler, Peter Malfertheiner, Waldemar Uhl, Hendrik Wolf, G. Schwab, H. G. Beger	1988	8
17	Safety and tolerability of the standardized quality house dust mite sublingual immunotherapy tablet in real life: A noninterventional, open-label study The Journal of Allergy and Clinical Immunology In Practice ·Rainer Reiber, Hendrik Wolf, Thomas Futschik, Jan-Alexander Schwab, U Hölscher, Jörg Schnitker, Eike Wüstenberg	2021	5
18	Tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with an optimized allergen to adjuvant ratio under routine practice conditions: a noninterventional observational study. PubMed ·B. Hauswald, Hendrik Wolf, Frauke Becker, Sven Becker, J Schnitker, E. G. Wüstenberg	2013	5
19	Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study Clinical and Translational Allergy ·Rainer Reiber, Martina Keller, Winfried Keller, Hendrik Wolf, Jörg Schnitker, Eike Wüstenberg	2015	4
20	Shortened Up-Dosing With 7 Injections of Subcutaneous Allergy Immunotherapy (Alutard SQ) Is Safe and Well Tolerated Journal of Investigational Allergology and Clinical Immunology ·Andreas Horn, Montserrat Fernández‐Rivas, Hendrik Wolf, Nadia Ghaussy, T Møller Kruse, Katerina Koutromanou, E. G. Wüstenberg	2020	3

About Hendrik Wolf

Hendrik Wolf is a scholar working on Immunology and Allergy, Physiology, Dermatology, Surgery and Pharmacology, having authored 30 papers that have together received 744 indexed citations. Recurring topics across this work include Allergic Rhinitis and Sensitization (25 papers), Asthma and respiratory diseases (15 papers), Dermatology and Skin Diseases (14 papers), Food Allergy and Anaphylaxis Research (7 papers), Ocular Surface and Contact Lens (2 papers), Healthcare and Venom Research (2 papers), Olfactory and Sensory Function Studies (2 papers) and Respiratory and Cough-Related Research (2 papers). The work is most often cited by research in Immunology and Allergy (577 citations), Dermatology (372 citations), Physiology (351 citations), Pulmonary and Respiratory Medicine (113 citations) and Sensory Systems (16 citations). Hendrik Wolf has collaborated with scholars based in Germany, Denmark and Belgium. Frequent co-authors include J Schnitker, Jörg Schnitker, Randolf Brehler, Bernhard Przybilla, Franziska Ruëff, Thomas Werfel, Margitta Worm, T. Ruzicka, Kristine Breuer and Ludger Klimek. Their work appears in journals such as Allergy, Journal of Allergy and Clinical Immunology, Clinical and Translational Allergy, World Allergy Organization Journal and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact